Latest Omnicare (OCR) Headlines Omnicare Earnin
Post# of 32
Omnicare Earnings Hindsight: Down 2.1% in Last 19 Days (OCR)
Comtex SmarTrend(R) - Mon Mar 10, 7:18AM CDT
19 days ago, on February 19th, 2014, Omnicare (NYSE:OCR) reported its earnings. Analysts, on average, expected earnings of $0.90 per share on sales of $1.6 billion. The company actually reported EPS of $0.90 on sales of $1.5 billion, missing EPS estimates by $0.00 and missing revenue estimates by $50.3 million. Since the company's report, shares of Omnicare have fallen from $60.98 to $59.68, representing a loss of 2.1% in the past 19 days.
3 Stocks Going Ex-Dividend Monday: TCAP, GLNG, OCR
at The Street - Fri Mar 07, 9:00AM CST
TCAP GLNG OCR are going ex-dividend Monday, Monday, March 10, 2014, 4:00 AM ET
Upgrade Alert for Omnicare (OCR)
Comtex SmarTrend(R) - Fri Mar 07, 7:06AM CST
Omnicare (NYSE:OCR) was upgraded from Neutral to Buy at UBS today. The stock closed yesterday at $57.73 on volume of 1.2 million shares, below average daily volume of 1.4 million. In the past 52 weeks, shares of Omnicare have traded between a low of $37.16 and a high of $64.87 and closed yesterday at $57.73, which is 55% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has declined 0.2%.
AG Gansler Secures $3.8 Million Settlement with Omnicare Inc. Maryland to receive nearly $67,000 to resolve kickback scheme allegations
M2 - Fri Mar 07, 3:30AM CST
Attorney General Douglas F. Gansler announced today that Maryland, joined by other states and the federal government, has secured a global settlement with Omnicare, Inc., a comprehensive provider of pharmacy and related services to long-term care and other specialized health care settings. The Maryland Medicaid program will receive $66,775.47, to be shared with the federal government, which provides a portion of Medicaid funding.
Omnicare to Pay Government $4.19 Million to Resolve False Claims Act Allegations of Kickbacks
M2 - Fri Feb 28, 6:17AM CST
Omnicare Inc., an Ohio-based long-term care pharmacy, has agreed to pay the government $4.19 million to settle allegations that it engaged in a kickback scheme in violation of the False Claims Act, the Justice Department announced today. Omnicare provides pharmaceuticals and services to long-term care facilities and residents and other senior populations.
Grant & Eisenhofer Represents Whistleblower in Latest Settlement Involving Improper Marketing of Drug Used on Nursing Home Patients
PR Newswire - Thu Feb 27, 5:31PM CST
Following on the heels of a $24.9 million settlement with Amgen last April, long-term care pharmacy Omnicare (NYSE: OCR) has resolved allegations that it received remuneration from Amgen in order to influence the selection and utilization of the drug Aranesp throughout the nations' nursing homes. Aranesp, with limited indications, is used to treat anemia.
Omnicare Shares Up 53.6% Since SmarTrend's Buy Recommendation (OCR)
Comtex SmarTrend(R) - Thu Feb 27, 9:10AM CST
SmarTrend identified an Uptrend for Omnicare (NYSE:OCR) on March 20th, 2013 at $38.92. In approximately 11 months, Omnicare has returned 53.62% as of today's recent price of $59.79.
Omnicare to Provide Medication Therapy Management Services for Certain Inland Empire Health Plan Members
Thomson Reuters ONE - Wed Feb 26, 7:01AM CST
CINCINNATI, February 26, 2014 - Omnicare, Inc. (NYSE: OCR) today announced it has partnered with Inland Empire Health Plan (IEHP) to provide Medication Therapy Management (MTM) services for the plan's members who reside in long-term care (LTC) facilities. Omnicare currently provides an MTM solution for WellCare Health Plans as well as several other health plans.
Omnicare Declares Quarterly Cash Dividend
Thomson Reuters ONE - Mon Feb 24, 7:41AM CST
CINCINNATI, February 24, 2014 - Omnicare, Inc. (NYSE:OCR), today announced that its Board of Directors has approved a quarterly cash dividend of $0.20 per share on the Company's common stock, to be paid on March 27, 2014, to all stockholders of record on March 12, 2014.
Omnicare Earnings Rise but Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 11:30AM CST
For full year 2013, OCR's adjusted net earnings per share grew 9.9% to $3.43 from $3.12 a year ago, also lagging the Zacks Consensus Estimate of $3.61.
Omnicare (OCR) Falls: Stock Goes Down 5.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 7:37AM CST
Omnicare Inc. (OCR) saw a big move last session. This stock, trading at a volatile range of $60.68–$64.54 in the past one-month time frame, showed a sharp decline yesterday at $60.98.
Omnicare misses, guides low
at Investor's Business Daily - Wed Feb 19, 5:54PM CST
The provider of consulting services and pharmacy distribution to long-term care facilities said Q4 EPS rose 1% to 87 cents, missing views by 2 cents. It's the 6th straight quarter of decelerating growth. Revenue rose 0.5% to $1.53 bil, under...
NYSE stocks posting largest volume increases
AP - Wed Feb 19, 5:13PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
SmarTrend Watching for Potential Rebound in Shares of Omnicare After 5.52% Loss
Comtex SmarTrend(R) - Wed Feb 19, 4:23PM CST
Omnicare (NYSE:OCR) traded in a range yesterday that spanned from a low of $59.26 to a high of $64.01. Yesterday, the shares fell 5.5%, which took the trading range below the 3-day low of $62.35 on volume of 5.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Trade-Ideas: Omnicare (OCR) Is Today's "Water-Logged And Getting Wetter" Stock
at The Street - Wed Feb 19, 2:22PM CST
Trade-Ideas LLC identified Omnicare (OCR) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
Omnicare Reports Fourth-Quarter and Full-Year 2013 Financial Results; Company Provides Full-Year 2014 Guidance
Thomson Reuters ONE - Wed Feb 19, 6:46AM CST
CINCINNATI, February 19, 2014 - Omnicare, Inc. (NYSE:OCR) reported today financial results for its fourth quarter and full year ended December 31, 2013.
Uptrend Call Working As Omnicare Stock Rises 61.4% (OCR)
Comtex SmarTrend(R) - Wed Feb 12, 11:01AM CST
SmarTrend identified an Uptrend for Omnicare (NYSE:OCR) on March 20th, 2013 at $38.92. In approximately 11 months, Omnicare has returned 61.38% as of today's recent price of $62.81.
Omnicare Has Returned 55.2% Since SmarTrend Recommendation (OCR)
Comtex SmarTrend(R) - Wed Feb 05, 9:37AM CST
SmarTrend identified an Uptrend for Omnicare (NYSE:OCR) on March 20th, 2013 at $38.92. In approximately 11 months, Omnicare has returned 55.19% as of today's recent price of $60.40.